Nigel Thompson worked as a stockbroker for Cantor Fitzgerald. His office was on the 105th floor of the North Tower of the World Trade Centre - the first twin tower that was attacked. Brother Neil ...

On Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on Health Catalyst Inc. (NASDAQ:HCAT) with a steady price target of $16.00. According to InvestingPro data, this target represents ...

Uber Technologies, Inc. (NYSE:UBER – Free Report) – Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Uber Technologies in a note issued to investors on Wednesday ...

Cantor Fitzgerald analyst D. Mathivanan now forecasts that the business services provider will post earnings per share of $197.85 for the year, down from their prior estimate of $208.81.

On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on Zai Lab (NASDAQ:ZLAB) despite recent market pressures. Trading at $24.32, Zai Lab stock has experienced significant downward ...

Cantor Fitzgerald views Bob Duggan’s, Summit Therapeutics (SMMT) co-CEO and Chairman, stock option exercise “quite unusual” and “quite bullish” for the shares. Duggan’ exercised ...

Cantor Fitzgerald doubled down on its bearish stance toward stocks on Monday, reaffirming its negative outlook with the statement, “we continue to be bearish on equities” in an investor note ...

Fintel reports that on April 15, 2025, Cantor Fitzgerald upgraded their outlook for Verve Therapeutics (NasdaqGS:VERV) from Neutral to Overweight. As of April 2, 2025, the average one-year price ...

Cantor Fitzgerald upgraded Denali Therapeutics (DNLI) to Overweight from Neutral. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your ...

Cantor Fitzgerald lowered the firm’s price target on DoorDash (DASH) to $210 from $230 and keeps an Overweight rating on the shares. The Q1 earnings season for the firm’s internet coverage ...